The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
03 2022
Historique:
received: 22 09 2021
revised: 10 01 2022
accepted: 15 01 2022
pubmed: 7 2 2022
medline: 5 4 2022
entrez: 6 2 2022
Statut: ppublish

Résumé

The Cognitive Assessment Interview (CAI) is an interview-based scale developed to measure cognitive impairment and its impact on functioning in subjects with schizophrenia (SCZ). Previous studies demonstrated good psychometric properties of the CAI. However, only relatively small samples of SCZ were investigated. This study aimed to determine in a large sample of SCZ (N = 580) the relationships of the Italian Version of the CAI with measures of cognitive performance and functional capacity and real-life functioning, using state-of-the-art instruments. Intraclass correlation coefficients (ICCs) and Cronbach's alpha were calculated to examine the CAI's inter-rater reliability and internal consistency. Pearson's correlation coefficients were used to evaluate relationships between CAI global and domain composite scores with neurocognition, social cognition, functional capacity, and functioning. The inter-rater reliability and internal consistency were good to excellent. The CAI global composite score showed a strong correlation with the MATRICS Consensus Cognitive Battery (MCCB) composite score (r = -0.50) and moderate/strong associations with measures of functional capacity (-0.46 < r < -0.52) and real-life functioning (-0.30 < r < -0.51). Finally, CAI composite social cognition score correlated moderately with the Facial Emotion Identification Test (r = -0.31) and two subscales of the Awareness of Social Inference Test (-0.32 < r < -0.34). The study suggests that CAI is a valid co-primary measure for clinical trials and a suitable instrument to screen impairment in neurocognitive and social cognitive domains and its impact on functioning in SCZ in everyday clinical practice.

Identifiants

pubmed: 35124435
pii: S0920-9964(22)00039-1
doi: 10.1016/j.schres.2022.01.029
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-170

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Giulia M Giordano (GM)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.

Davide Palumbo (D)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.

Armida Mucci (A)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy. Electronic address: armida.mucci@gmail.com.

Joseph Ventura (J)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.

Luigi Giuliani (L)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.

Andrea Perrottelli (A)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.

Paola Bucci (P)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.

Paola Rocca (P)

Department of Neuroscience, Section of Psychiatry, University of Turin, Turin, Italy.

Alessandro Rossi (A)

Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Alessandro Bertolino (A)

Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy.

Paola Rucci (P)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Silvana Galderisi (S)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.

Mario Maj (M)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH